Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0U3UJ
|
||||
| Former ID |
DIB014665
|
||||
| Drug Name |
CHT-25
|
||||
| Indication | Hodgkin's lymphoma [ICD10:C81] | Phase 1 | [530581] | ||
| Company |
University College London
|
||||
| Target and Pathway | |||||
| Target(s) | Interleukin-2 receptor alpha chain | Target Info | Modulator | [530581] | |
| PANTHER Pathway | Interleukin signaling pathway | ||||
| Pathway Interaction Database | IL12-mediated signaling events | ||||
| Calcineurin-regulated NFAT-dependent transcription in lymphocytes | |||||
| Arf6 trafficking events | |||||
| SHP2 signaling | |||||
| IL2-mediated signaling events | |||||
| IL2 signaling events mediated by PI3K | |||||
| IL2 signaling events mediated by STAT5 | |||||
| Calcium signaling in the CD4+ TCR pathway | |||||
| Downstream signaling in naï | |||||
| IL12 signaling mediated by STAT4 | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.